Harrow Historical Income Statement

HROW Stock

USD 42.47 0.23 0.54%

Historical analysis of Harrow Health income statement accounts such as Selling And Marketing Expenses of 37.7 M or Other Operating Expenses of 136.3 M can show how well Harrow Health performed in making a profits. Evaluating Harrow Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Harrow Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Harrow Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Harrow Health is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.

About Harrow Income Statement Analysis

Harrow Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Harrow Health shareholders. The income statement also shows Harrow investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Harrow Health Income Statement Chart

At this time, Harrow Health's Depreciation And Amortization is fairly stable compared to the past year. Total Revenue is likely to climb to about 136.7 M in 2024, despite the fact that Income Before Tax is likely to grow to (22.7 M).

Selling General Administrative Selling And Marketing Expenses Other Operating Expenses Operating Income Ebit Research Development

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Harrow Health. It is also known as Harrow Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Harrow Health operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Harrow Health is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from Harrow Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Harrow Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.At this time, Harrow Health's Depreciation And Amortization is fairly stable compared to the past year. Total Revenue is likely to climb to about 136.7 M in 2024, despite the fact that Income Before Tax is likely to grow to (22.7 M).

	2021	2022	2023	2024 (projected)
Gross Profit	54.3M	63.2M	90.6M	95.1M
Total Revenue	72.5M	88.6M	130.2M	136.7M

Gross Profit Total Revenue

Harrow Health income statement Correlations

	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Depreciation And Amortization	Net Income From Continuing Ops	Non Operating Income Net Other	Total Revenue	Gross Profit	Cost Of Revenue	Interest Income	Tax Provision	Net Interest Income	Minority Interest	Reconciled Depreciation	Non Recurring
Interest Expense		0.93	0.66	0.93	0.37	0.15	0.66	0.62	0.93	-0.63	-0.73	-0.65	0.09	0.98	-0.66	-0.41	0.91	0.9	0.94	0.23	0.75	-0.97	0.47	0.96	-0.69
Selling General Administrative	0.93		0.77	0.96	0.43	0.1	0.71	0.55	0.96	-0.54	-0.69	-0.56	0.0	0.91	-0.57	-0.38	0.95	0.95	0.95	0.33	0.72	-0.89	0.62	0.87	-0.7
Selling And Marketing Expenses	0.66	0.77		0.86	0.58	0.33	0.69	0.61	0.85	-0.14	-0.45	-0.17	-0.21	0.72	-0.18	-0.14	0.89	0.88	0.84	0.55	0.64	-0.58	0.79	0.61	-0.78
Other Operating Expenses	0.93	0.96	0.86		0.44	0.14	0.74	0.59	1.0	-0.54	-0.71	-0.56	0.01	0.94	-0.57	-0.39	0.99	0.99	0.98	0.35	0.71	-0.88	0.66	0.87	-0.81
Operating Income	0.37	0.43	0.58	0.44		0.78	0.55	0.81	0.44	0.13	-0.46	0.1	0.05	0.46	0.06	-0.31	0.54	0.58	0.51	0.13	0.59	-0.45	0.62	0.46	-0.58
Ebit	0.15	0.1	0.33	0.14	0.78		0.04	0.86	0.12	0.41	-0.08	0.38	-0.03	0.28	0.37	0.09	0.22	0.24	0.24	0.1	0.5	-0.23	0.38	0.31	-0.22
Research Development	0.66	0.71	0.69	0.74	0.55	0.04		0.37	0.76	-0.53	-0.78	-0.55	0.16	0.65	-0.57	-0.64	0.77	0.79	0.7	0.11	0.64	-0.65	0.6	0.6	-0.81
Ebitda	0.62	0.55	0.61	0.59	0.81	0.86	0.37		0.58	0.01	-0.43	-0.02	0.02	0.73	-0.04	-0.13	0.65	0.66	0.67	0.21	0.76	-0.67	0.56	0.74	-0.53
Total Operating Expenses	0.93	0.96	0.85	1.0	0.44	0.12	0.76	0.58		-0.57	-0.73	-0.59	0.04	0.93	-0.6	-0.43	0.99	0.99	0.98	0.32	0.72	-0.88	0.66	0.87	-0.83
Income Before Tax	-0.63	-0.54	-0.14	-0.54	0.13	0.41	-0.53	0.01	-0.57		0.82	1.0	-0.62	-0.54	0.99	0.78	-0.49	-0.5	-0.47	0.43	-0.34	0.61	-0.2	-0.56	0.5
Total Other Income Expense Net	-0.73	-0.69	-0.45	-0.71	-0.46	-0.08	-0.78	-0.43	-0.73	0.82		0.83	-0.61	-0.7	0.85	0.91	-0.72	-0.75	-0.67	0.36	-0.63	0.75	-0.54	-0.71	0.8
Net Income	-0.65	-0.56	-0.17	-0.56	0.1	0.38	-0.55	-0.02	-0.59	1.0	0.83		-0.63	-0.56	0.99	0.78	-0.52	-0.52	-0.49	0.43	-0.37	0.62	-0.26	-0.57	0.51
Income Tax Expense	0.09	0.0	-0.21	0.01	0.05	-0.03	0.16	0.02	0.04	-0.62	-0.61	-0.63		0.08	-0.62	-0.73	0.02	0.05	-0.02	-0.91	0.05	-0.13	0.28	0.14	-0.17
Depreciation And Amortization	0.98	0.91	0.72	0.94	0.46	0.28	0.65	0.73	0.93	-0.54	-0.7	-0.56	0.08		-0.58	-0.37	0.93	0.92	0.95	0.25	0.77	-0.97	0.54	0.98	-0.71
Net Income From Continuing Ops	-0.66	-0.57	-0.18	-0.57	0.06	0.37	-0.57	-0.04	-0.6	0.99	0.85	0.99	-0.62	-0.58		0.81	-0.53	-0.54	-0.5	0.42	-0.38	0.65	-0.24	-0.59	0.55
Non Operating Income Net Other	-0.41	-0.38	-0.14	-0.39	-0.31	0.09	-0.64	-0.13	-0.43	0.78	0.91	0.78	-0.73	-0.37	0.81		-0.41	-0.45	-0.34	0.6	-0.36	0.47	-0.31	-0.4	0.65
Total Revenue	0.91	0.95	0.89	0.99	0.54	0.22	0.77	0.65	0.99	-0.49	-0.72	-0.52	0.02	0.93	-0.53	-0.41		1.0	0.98	0.34	0.74	-0.87	0.7	0.87	-0.85
Gross Profit	0.9	0.95	0.88	0.99	0.58	0.24	0.79	0.66	0.99	-0.5	-0.75	-0.52	0.05	0.92	-0.54	-0.45	1.0		0.97	0.31	0.76	-0.87	0.72	0.86	-0.87
Cost Of Revenue	0.94	0.95	0.84	0.98	0.51	0.24	0.7	0.67	0.98	-0.47	-0.67	-0.49	-0.02	0.95	-0.5	-0.34	0.98	0.97		0.38	0.71	-0.9	0.64	0.9	-0.77
Interest Income	0.23	0.33	0.55	0.35	0.13	0.1	0.11	0.21	0.32	0.43	0.36	0.43	-0.91	0.25	0.42	0.6	0.34	0.31	0.38		0.15	-0.15	0.07	0.16	-0.1
Tax Provision	0.75	0.72	0.64	0.71	0.59	0.5	0.64	0.76	0.72	-0.34	-0.63	-0.37	0.05	0.77	-0.38	-0.36	0.74	0.76	0.71	0.15		-0.79	0.51	0.8	-0.65
Net Interest Income	-0.97	-0.89	-0.58	-0.88	-0.45	-0.23	-0.65	-0.67	-0.88	0.61	0.75	0.62	-0.13	-0.97	0.65	0.47	-0.87	-0.87	-0.9	-0.15	-0.79		-0.43	-0.99	0.67
Minority Interest	0.47	0.62	0.79	0.66	0.62	0.38	0.6	0.56	0.66	-0.2	-0.54	-0.26	0.28	0.54	-0.24	-0.31	0.7	0.72	0.64	0.07	0.51	-0.43		0.46	-0.6
Reconciled Depreciation	0.96	0.87	0.61	0.87	0.46	0.31	0.6	0.74	0.87	-0.56	-0.71	-0.57	0.14	0.98	-0.59	-0.4	0.87	0.86	0.9	0.16	0.8	-0.99	0.46		-0.65
Non Recurring	-0.69	-0.7	-0.78	-0.81	-0.58	-0.22	-0.81	-0.53	-0.83	0.5	0.8	0.51	-0.17	-0.71	0.55	0.65	-0.85	-0.87	-0.77	-0.1	-0.65	0.67	-0.6	-0.65

Click cells to compare fundamentals

Harrow Health Account Relationship Matchups

Harrow Health income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	2.5M	2.2M	5.4M	7.2M	21.3M	22.4M
Selling General Administrative	33.1M	31.2K	41.3M	58.2M	83.1M	87.2M
Other Operating Expenses	51.9M	48.1M	70.6M	86.7M	129.8M	136.3M
Operating Income	(503K)	(1.6M)	(284K)	(1.7M)	580K	609K
Ebit	(503K)	748K	(12.5M)	(6.9M)	(2.6M)	(2.7M)
Research Development	2.1M	2.4M	11.1M	3.1M	6.9M	7.2M
Ebitda	2.2M	3.5M	(10.1M)	(3.2M)	9.7M	10.2M
Total Operating Expenses	35.2M	33.7M	52.4M	61.3M	90.1M	94.6M
Income Before Tax	(125K)	(3.4M)	(17.9M)	(14.0M)	(23.9M)	(22.7M)
Total Other Income Expense Net	378K	(3.8M)	(19.5M)	(15.9M)	(24.5M)	(23.3M)
Net Income	(2.6M)	(3.4M)	(18.0M)	(14.1M)	(24.4M)	(23.2M)
Income Tax Expense	2.5M	4K	133K	75K	470K	493.5K
Depreciation And Amortization	2.7M	2.7M	2.4M	3.7M	12.3M	13.0M
Net Income From Continuing Ops	(125K)	(3.4M)	(18.0M)	(14.1M)	(24.4M)	(23.2M)
Non Operating Income Net Other	7.2M	(73K)	(14.1M)	(8.7M)	(7.8M)	(7.4M)
Net Income Applicable To Common Shares	168K	(3.4M)	(18.5M)	(14.1M)	(12.7M)	(12.0M)
Total Revenue	51.2M	48.9M	72.5M	88.6M	130.2M	136.7M
Gross Profit	34.4M	34.4M	54.3M	63.2M	90.6M	95.1M
Cost Of Revenue	16.7M	14.5M	18.2M	25.4M	39.6M	41.6M
Net Interest Income	(2.5M)	(2.2M)	(5.4M)	(7.2M)	(21.3M)	(20.3M)
Reconciled Depreciation	2.7M	2.7M	2.4M	3.7M	12.3M	13.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Harrow Stock Analysis

When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Harrow Historical Income Statement

About Harrow Income Statement Analysis

Harrow Health Income Statement Chart

Other Operating Expenses

Operating Income

Harrow Health income statement Correlations

Harrow Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Harrow Health income statement Accounts

Also Currently Popular

Additional Tools for Harrow Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Net Income	+ 1.0	Income Before Tax
Gross Profit	+ 1.0	Total Revenue
Total Revenue	+ 0.99	Other Operating Expenses
Gross Profit	+ 0.99	Other Operating Expenses
Total Revenue	+ 0.99	Total Operating Expenses

Reconciled Depreciation	- 0.99	Net Interest Income
Net Interest Income	- 0.97	Depreciation And Amortization
Net Interest Income	- 0.97	Interest Expense
Interest Income	- 0.91	Income Tax Expense
Net Interest Income	- 0.9	Cost Of Revenue
Net Interest Income	- 0.89	Selling General Administrative